Frequently Asked Questions

Get answers to common questions about Semaglutide – 2 Month Special.

Many clients notice appetite suppression and modest weight loss within two to four weeks, with more significant changes commonly by six to eight weeks. Individual results vary; our providers monitor progress and adjust dosing for safe, measurable outcomes during the two-month program.

Common side effects include nausea, mild vomiting, diarrhea, and constipation, usually transient during dose escalation. We provide guidance, slow titration, and clinical support to manage symptoms; contact our team if effects persist or worsen for individualized intervention.

Good candidates generally have a BMI over 27 with weight-related comorbidities or higher BMI and have tried lifestyle measures. A medical evaluation, medications review, and pregnancy screening determine eligibility; our clinicians assess safety and personalize the plan.

Semaglutide is given as a weekly subcutaneous injection. We teach self-administration techniques at your visit, provide dosing schedules, and offer clinic support for first doses, side-effect management, and any questions during the two-month program.

Coverage varies: many insurers exclude GLP-1 medications for cosmetic weight loss, while some cover them with qualifying diagnoses. We provide documentation, prior authorization assistance, and transparent self-pay pricing so you can choose the best option.

After two months we review results and recommend next steps: continue maintenance dosing, extend therapy, or transition to lifestyle-focused support. Our team creates a follow-up plan, addresses long-term goals, and discusses tapering or ongoing monitoring if needed.